iShares US Pharmaceuticals ETF
IHE
IHE
86 hedge funds and large institutions have $259M invested in iShares US Pharmaceuticals ETF in 2014 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 25 increasing their positions, 34 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less ownership
Funds ownership: →
14% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 7
26% less repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 34
Holders
86
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$3.72M | |
| 2 | +$3.46M | |
| 3 | +$2.33M | |
| 4 |
AWA
ARS Wealth Advisors
St. Petersburg,
Florida
|
+$1.55M |
| 5 |
ACM
Avalon Capital Management
Port Of Redwood City,
California
|
+$1.33M |
Top Sellers
| 1 | -$6.49M | |
| 2 | -$4.71M | |
| 3 | -$3.43M | |
| 4 |
VKH
Virtu KCG Holdings
New York
|
-$3.2M |
| 5 |
Wells Fargo
San Francisco,
California
|
-$2.83M |